Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Cell Death and Differentiation
|
February 21, 2012
Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism
C Iorio-Morin, P Germain, S Roy, et al.
Endocrine-Related Cancer
|
April 1, 2021
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches
Mark P Labrecque, Joshi J Alumkal, Ilsa M Coleman, et al.
Plos One
|
May 14, 2014
Epigenetic characterization of the growth hormone gene identifies SmcHD1 as a regulator of autosomal gene clusters
Shabnam Massah, Robert Hollebakken, Mark P Labrecque, et al.
Chemico-Biological Interactions
|
February 17, 2015
p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines
Lilian I L Wong, Mark P Labrecque, Naokazu Ibuki, et al.
Plos One
|
January 12, 2012
Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines
Mark P Labrecque, Mandeep K Takhar, Brett D Hollingshead, et al.
Free Radical Biology & Medicine
|
November 5, 2018
Expression of human inducible nitric oxide synthase in response to cytokines is regulated by hypoxia-inducible factor-1
Martin Lee, Christine Wang, Steven W Jin, et al.
Scientific Reports
|
August 12, 2017
Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer
S Khakshour, M P Labrecque, H Esmaeilsabzali, et al.
Plos One
|
January 20, 2021
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 19, 2010
Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity
Gary H Perdew, Brett D Hollingshead, Brett C Dinatale, et al.
Plos One
|
June 12, 2014
A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1α-mediated transcription and cancer cell invasion
Mark P Labrecque, Mandeep K Takhar, Julienne M Jagdeo, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Cell Death and Differentiation
|
February 21, 2012
Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism
C Iorio-Morin, P Germain, S Roy, et al.
Endocrine-Related Cancer
|
April 1, 2021
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches
Mark P Labrecque, Joshi J Alumkal, Ilsa M Coleman, et al.
Plos One
|
May 14, 2014
Epigenetic characterization of the growth hormone gene identifies SmcHD1 as a regulator of autosomal gene clusters
Shabnam Massah, Robert Hollebakken, Mark P Labrecque, et al.
Chemico-Biological Interactions
|
February 17, 2015
p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines
Lilian I L Wong, Mark P Labrecque, Naokazu Ibuki, et al.
Plos One
|
January 12, 2012
Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines
Mark P Labrecque, Mandeep K Takhar, Brett D Hollingshead, et al.
Free Radical Biology & Medicine
|
November 5, 2018
Expression of human inducible nitric oxide synthase in response to cytokines is regulated by hypoxia-inducible factor-1
Martin Lee, Christine Wang, Steven W Jin, et al.
Scientific Reports
|
August 12, 2017
Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer
S Khakshour, M P Labrecque, H Esmaeilsabzali, et al.
Plos One
|
January 20, 2021
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 19, 2010
Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity
Gary H Perdew, Brett D Hollingshead, Brett C Dinatale, et al.
Plos One
|
June 12, 2014
A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1α-mediated transcription and cancer cell invasion
Mark P Labrecque, Mandeep K Takhar, Julienne M Jagdeo, et al.
Page
of 4